Provided by Tiger Trade Technology Pte. Ltd.

Applied Therapeutics Inc.

0.1154
-0.0003-0.26%
Post-market: 0.1126-0.0028-2.43%16:58 EST
Volume:35.00M
Turnover:4.34M
Market Cap:16.65M
PE:-0.90
High:0.1170
Open:0.1117
Low:0.1100
Close:0.1157
52wk High:1.50
52wk Low:0.1000
Shares:144.30M
Float Shares:120.21M
Volume Ratio:10.84
T/O Rate:29.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1280
EPS(LYR):-0.7570
ROE:-680.47%
ROA:-88.35%
PB:-29.68
PE(LYR):-0.15

Loading ...

Applied Therapeutics Director Stacy J. Kanter Reports Disposal of Common Shares

Reuters
·
Dec 19

BUZZ-U.S. STOCKS ON THE MOVE-EastGroup, Boeing, Exxon Mobil

Reuters
·
Dec 13

BUZZ-U.S. STOCKS ON THE MOVE-ProPetro, Nvidia, Citigroup

Reuters
·
Dec 12

Applied Therapeutics Shares Tumble 48.2% to an All-Time Low After Cycle Therapeutics to Buy Co at $0.088 per Share

THOMSON REUTERS
·
Dec 12

BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Gold miners, Silver miners

Reuters
·
Dec 12

BUZZ-Applied Therapeutics plunges after UK's Cycle Group to buy co

Reuters
·
Dec 12

Applied Therapeutics Shares Slump 35% Premarket After Cycle Therapeutics to Buy Co at $0.088 per Share

THOMSON REUTERS
·
Dec 12

Cycle Pharmaceuticals to Acquire Applied Therapeutics for $0.088 Per Share Plus CVR

Reuters
·
Dec 12

NASDAQ TRADE HALT HALT NEWS PENDING AT 05:21 PM

Reuters
·
Dec 12

Applied Therapeutics Cuts Workforce and Explores Strategic Alternatives

Reuters
·
Nov 20

Applied Therapeutics Inc - to Reduce Workforce by 46%

THOMSON REUTERS
·
Nov 20

Applied Therapeutics: Expects to Submit Request for Additional Type C Meeting With FDA to Further Discuss Potential Phase 3 Trial Design

THOMSON REUTERS
·
Nov 20

RBC Capital Remains a Hold on Applied Therapeutics (APLT)

TIPRANKS
·
Nov 15

Are Applied Therapeutics' (APLT) Narrowing Losses a Turning Point for Its Strategic Vision?

Simply Wall St.
·
Nov 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO)

TIPRANKS
·
Nov 14

Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain

Benzinga_recent_news
·
Nov 14

Applied Therapeutics Q3 net loss of $19 mln beats expectations

Reuters
·
Nov 13

Applied Therapeutics Reports Q3 2025 Results and Board Leadership Transition

Reuters
·
Nov 13

Applied Therapeutics Q3 EPS USD -0.13

THOMSON REUTERS
·
Nov 13

Applied Therapeutics Inc -in Nov, John Johnson to Step Down as Executive Chairman

THOMSON REUTERS
·
Nov 13